1 results match your criteria: "The Affiliated Hospital of Jiangsu University (Zhenjiang Municipal Jiangbin Hospital)[Affiliation]"
[Clinical Efficacy of Decitabine Combined with Modified CAG Regimen for Relapse/Refractory Acute Myeloid Leukemia with AML1-ETO].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2016
Department of Hematology, The Affiliated Hospital of Jiangsu University (Zhenjiang Municipal Jiangbin Hospital), Zhenjiang 212008, Jiangsu Province, China. E-mail:
Objective: To investigate the clinical characteristics of patients with relapse-refractory acute myeloid leukemia(AML) with AML1-ETO, and therapeutic effcacy and side effects of decitabine combined with modified CAG regimen.
Methods: Clinical data of 8 cases of AML with AML1-ETO from June 2015 to January 2016 were analyzed retrospectively, including age, sex, initial symptoms, peripheral blood and bone marrow characteristics and so on. at the same time, the therapeutic effcacy and side effects of decitabine combined with modified CAG regimen were evaluated.